Imperial College London


Faculty of MedicineSchool of Public Health

Deputy Head of Statistics



+44 (0)20 7594 1846e.falaschetti




Stadium HouseWhite City Campus





Emanuela Falaschetti is a Research Fellow in Clinical Trial Statistics at the Imperial Clinical Trial Unit (ICTU), School of Public Health. She is involved in all stages of clinical trials, from design to analysis and reporting. She graduated (MSc) in Statistics at Bologna University and she is Chartered statistician (CStat) member of the Royal Statistical Society. Before joining Imperial College she was Research Associate at the Department of Epidemiology and Public Health, University College London (UCL) from 1999 to 2009, working on the Heath Survey for England and Senior Research Associate at the Vascular Physiology Unit, Institute of Cardiovascular Science, UCL from 2009 to 2011, involved in different projects (cohort studies and interventional trials). Her main areas of research are in cardiovascular, metabolic and respiratory fields.



Barbera M, Lehtisalo J, Perera D, et al., 2024, A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol., Alzheimers Res Ther, Vol:16

Kanagaratnam P, McCready J, Tayebjee M, et al., 2023, Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial, Ep Europace, Vol:25, ISSN:1099-5129, Pages:863-872

Whinnett ZI, Shun-Shin MJ, Tanner M, et al., 2023, Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial, European Journal of Heart Failure, Vol:25, ISSN:1388-9842, Pages:274-283

Lee MJ, Collins S, Babalis D, et al., 2022, The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial, Trials, Vol:23, ISSN:1745-6215

Ruban A, Miras A, glaysher M, et al., 2022, Duodenal-jejunal bypass liner for the management of Type 2 diabetes and obesity: a multicenter randomized controlled trial, Annals of Surgery, Vol:275, ISSN:0003-4932, Pages:440-447

More Publications